产品编号 | CFN91808 | |
CAS编号 | 83480-29-9 | |
分子式 = 分子量 | C10H21NO7 = 267.3 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Miscellaneous | |
植物来源 | ||
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
伏格列波糖 | CFN91808 | 83480-29-9 | 10mg | QQ客服:1413575084 |
伏格列波糖 | CFN91808 | 83480-29-9 | 20mg | QQ客服:1413575084 |
伏格列波糖 | CFN91808 | 83480-29-9 | 50mg | QQ客服:1413575084 |
伏格列波糖 | CFN91808 | 83480-29-9 | 100mg | QQ客服:1413575084 |
Description: | Voglibose is an orally active alpha-glucosidase inhibitor that prevents the development of colorectal precancerous lesions induced by obesity and diabetes. Voglibose reduces oxidative stress in an inflammatory environment and inhibits the insulin-like growth factor/insulin-like growth factor-1 receptor (IGF/IGF-1R) functional axis. Voglibose (Glustat), an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against α-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia. |
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.7411 mL | 18.7056 mL | 37.4111 mL | 74.8223 mL | 93.5279 mL |
5 mM | 0.7482 mL | 3.7411 mL | 7.4822 mL | 14.9645 mL | 18.7056 mL |
10 mM | 0.3741 mL | 1.8706 mL | 3.7411 mL | 7.4822 mL | 9.3528 mL |
50 mM | 0.0748 mL | 0.3741 mL | 0.7482 mL | 1.4964 mL | 1.8706 mL |
100 mM | 0.0374 mL | 0.1871 mL | 0.3741 mL | 0.7482 mL | 0.9353 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
(S)-2-甲基-1-(2,4,6-三羟基-3-甲基苯基)-1-丁酮 ; 2-Methyl-4-(2-methylbutyryl)phloroglucinol | CFN96868 | 124598-11-4 | C12H16O4 = 224.25 | 5mg | QQ客服:2159513211 |
甜菊糖苷; Steviolmonoside | CFN91504 | 60129-60-4 | C26H40O8 = 480.6 | 5mg | QQ客服:1413575084 |
Cinalbicol; Cinalbicol | CFN89175 | 69904-85-4 | C15H20O = 216.32 | 5mg | QQ客服:1457312923 |
蚕沙酮; Bombiprenone | CFN98090 | 21978-49-4 | C43H70O = 603.0 | 5mg | QQ客服:2159513211 |